crossover_review
TL3 Regular · Plovdiv, BG
Clinician. Posts general information only, and says so every time.
Joined 5 January 2025 · last posted 4d · groups: clinicians, regional-apac
143 posts, newest first. Showing up to 150.
-
Common supplements people ask about, assessed one at a time Replied, post #89 · Practice › Interactions · 24 Jul 2026 · 28 likes Supplements and herbs: many have no established interaction. Some do. If you are taking something unusual, checking a reference (like a pharmacist) is more useful than…
-
Rewriting my first post: a before-and-after, with commentary — what changed since Replied, post #18 · Start Here › How to Ask · 21 Jul 2026 · 28 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
What a certificate commits its issuer to — one year on Replied, post #114 · Analytics › COA interpretation · 21 Jul 2026 · 16 likes On post #110 — agreed on the reasoning, with one qualification. A certificate of analysis is a statement by its issuer that a defined test was performed on a defined…
-
GLP-1 receptor distribution: central and peripheral Replied, post #94 · Pharmacology › Receptor biology · 20 Jul 2026 · 3 likes Glucagon receptor agonism: glucagon receptor agonism increases energy expenditure and promotes hepatic fat oxidation. The mechanism is distinct from GLP-1 and GIP…
-
Private prescribing in the UK: what is actually involved Replied, post #69 · Regional › UK & Ireland · 19 Jul 2026 · 13 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Spreadsheets: an appreciation — what changed since Replied, post #100 · Lounge › Off topic · 14 Jul 2026 · 7 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Follow-up: Reading an interaction checker output critically Replied, post #39 · Practice › Interactions · 9 Jul 2026 · 0 likes post #38 answers the question as asked. The question underneath it is different. Supplements and herbs: many have no established interaction. Some do. If you are taking…
-
Asking a follow-up: new topic or new reply? Replied, post #40 · Start Here › How to Ask · 6 Jul 2026 · 13 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Revisiting: How this community labels and discusses unrefereed work Replied, post #16 · Evidence › Preprints · 5 Jul 2026 · 2 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #57 · Evidence › Journal club · 4 Jul 2026 · 3 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Pages past their review date, listed — does this still hold? Replied, post #30 · Meta › Wiki maintenance · 29 Jun 2026 · 10 likes Review dates: each maintained page has a review date (the date by which it should be checked). If a page is past its review date, flagging it here alerts the maintainer.
-
Revisiting: The best-written scientific paper you have read Replied, post #54 · Lounge › Off topic · 26 Jun 2026 · 0 likes post #53 is right about the mechanism and I think understates the practical bit. Industry and supply chain: post about manufacturing, pharmaceutical economics, or…
-
How shortages have affected compounding permissions Started this topic · Access › Shortages · 26 Jun 2026 · 27 likes How shortages have affected compounding permissions I have a specific reason for asking rather than idle curiosity, and the context is below. A coverage question with…
-
Second pass at: Which categories are strict and which are relaxed, honestly Replied, post #80 · Start Here › Welcome · 23 Jun 2026 · 12 likes The FAQ link in the sidebar is maintained and worth ten hours of forum browsing. It is not comprehensive but it is well indexed for the questions that come up most.
-
Endotoxin and why it is a separate question from purity — what changed since Replied, post #50 · Analytics › Impurities & related substances · 18 Jun 2026 · 20 likes Coming back to post #48, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #40 · Evidence › Journal club · 17 Jun 2026 · 26 likes SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg dose is not the highest available, which is the central and…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #106 · Practice › Reconstitution · 13 Jun 2026 · 8 likes A 10 mg vial reconstituted three different ways: 1 mL diluent gives 10 mg/mL, 2 mL gives 5 mg/mL, 4 mL gives roughly 2.5 mg/mL. The arithmetic is the same; the…
-
Revisiting: The best-written scientific paper you have read Replied, post #21 · Lounge › Off topic · 8 Jun 2026 · 29 likes Picking up post #18: that is the part I would want checked first. Politics and public policy: healthcare policy that affects access to these compounds is relevant here.…
-
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #41 · Practice › Storage & stability · 1 Jun 2026 · 1 like I want to gently push back on the reply above about storage extrapolation. The advice is sound and the confidence is not. We are extrapolating from stability data on a…
-
What published stability data actually covers, and what it does not Replied, post #4 · Practice › Storage & stability · 31 May 2026 · 26 likes Dating prepared solutions: write the date reconstitution on the vial in permanent marker. If you later need to know whether it has been sitting for weeks or days, the…
-
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #18 · Compounds › Secretagogues & GH axis · 31 May 2026 · 11 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Prescription requirements and telehealth models — a second dataset Replied, post #43 · Sourcing › Regulatory · 27 May 2026 · 0 likes Why this category is maintained as documentation, not as recommendations: the goal is factual accuracy and sourcing, not endorsement of any specific regulatory position.
-
Second pass at: Temperature logging at home: what is worth the effort Replied, post #7 · Practice › Storage & stability · 17 May 2026 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Reading a trial's population section before its results Replied, post #26 · Evidence › Trials · 16 May 2026 · 18 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Forced degradation studies: designing one that is informative Replied, post #52 · Analytics › Method validation · 9 May 2026 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Restarting after a long gap: what the labelling implies — the long version Replied, post #14 · Practice › Dosing & titration · 7 May 2026 · 3 likes The four-week escalation interval is a convention from the pivotal trials, not a pharmacological constant. The pharmacological argument is that with a week-long…
-
Foaming during reconstitution and whether it matters — the long version Replied, post #117 · Practice › Reconstitution · 29 Apr 2026 · 22 likes I read post #115 twice before replying, because I had assumed the opposite. A 10 mg vial reconstituted three different ways: 1 mL diluent gives 10 mg/mL, 2 mL gives 5…
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #50 · Evidence › Journal club · 29 Apr 2026 · 13 likes SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg dose is not the highest available, which is the central and…
-
Second pass at: What a 2 ppm match establishes, and what it does not Replied, post #7 · Analytics › Mass spectrometry · 26 Apr 2026 · 22 likes Resolution: "high resolution" commonly means
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #130 · Practice › Reconstitution · 26 Apr 2026 · 27 likes Coming back to post #128, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #17 · Practice › Reconstitution · 18 Apr 2026 · 10 likes Swirling versus inverting versus leaving it alone: the vial can be gently warmed (hands around it) and swirled with a rolling motion. Vigorous shaking introduces air…
-
List price versus negotiated price versus what you pay Replied, post #114 · Access › Pricing · 17 Apr 2026 · 6 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
List price versus negotiated price versus what you pay Replied, post #98 · Access › Pricing · 16 Apr 2026 · 10 likes This follows post #95 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
What "marked as solution" means and who gets to mark it — does this still hold? Replied, post #64 · Start Here › Welcome · 10 Apr 2026 · 0 likes This follows post #61 rather than contradicting it. Off-topic posts that do not belong here belong in the Lounge instead. You are not in trouble if a moderator moves…
-
Grapefruit: why this class is not the class that cares Replied, post #112 · Practice › Interactions · 2 Apr 2026 · 22 likes This follows post #109 rather than contradicting it. Anticoagulants: no direct interaction with the compounds in this class. Weight loss and body composition changes…
-
Foaming during reconstitution and whether it matters — the long version Replied, post #73 · Practice › Reconstitution · 23 Mar 2026 · 5 likes Swirling versus inverting versus leaving it alone: the vial can be gently warmed (hands around it) and swirled with a rolling motion. Vigorous shaking introduces air…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #114 · Access › Pricing · 13 Mar 2026 · 5 likes Pharmacy acquisition cost: a pharmacy pays less than the patient pays, even at insurance rates. That margin is where the pharmacy's costs and profit live.
-
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #32 · Lounge › Introductions · 10 Mar 2026 · 0 likes post #31 is right about the mechanism and I think understates the practical bit. Community culture: introductions give you a sense of who is here. Reading a few…
-
Follow-up: Bug report: the reconstitution calculator and a rounding edge case Replied, post #62 · Data & Tools › Calculators · 3 Mar 2026 · 0 likes On post #58 — agreed on the reasoning, with one qualification. Precision and significant figures: the calculators do not round to match your input precision. If you…
-
Coming back to: Why most self-reports here are not experiments, and that is fine Replied, post #48 · Research Methods › N-of-1 designs · 22 Feb 2026 · 6 likes Washout periods: after stopping a medication, how long does it take for the effect to wash out? For compounds with a week-long half-life, roughly a month is needed to…
-
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #65 · Start Here › How to Ask · 19 Feb 2026 · 7 likes Coming back to post #63, because the follow-up matters more than the original answer. What you have already read matters. Saying "I read the maintained page on this and…
-
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #94 · Documentation › Wiki requests · 17 Feb 2026 · 31 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Foaming during reconstitution and whether it matters — the long version Replied, post #37 · Practice › Reconstitution · 17 Feb 2026 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Packaging that arrived damaged: documenting it properly — a second dataset Replied, post #37 · Sourcing › Logistics · 12 Feb 2026 · 4 likes I read post #35 twice before replying, because I had assumed the opposite. Packaging integrity on arrival: if a parcel arrives with compromised packaging, that is…
-
Manufacturer assistance programmes and their eligibility rules Replied, post #5 · Access › Pricing · 11 Feb 2026 · 3 likes Pharmacy acquisition cost: a pharmacy pays less than the patient pays, even at insurance rates. That margin is where the pharmacy's costs and profit live.
-
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #24 · Outcomes › Progress reports · 9 Feb 2026 · 2 likes I read post #22 twice before replying, because I had assumed the opposite. Menstrual cycle: for people who menstruate, weight can shift by several pounds across the…
-
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #13 · Practice › Administration · 27 Jan 2026 · 0 likes A genuinely late dose: the labelling generally says that if the next dose is more than a couple of days away, take it as soon as you notice. If the next dose is close,…
-
Pen mechanics when the cartridge is nearly empty — does this still hold? Replied, post #42 · Devices › Pens & autoinjectors · 11 Jan 2026 · 11 likes Priming: most pens require priming before the first use (injecting a small amount to fill the needle and line). Not priming can result in no dose being delivered on the…
-
Guidelines revision: what changed and why — one year on Replied, post #56 · Meta › Announcements · 9 Jan 2026 · 26 likes post #55 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Aggregates and why a purity assay may miss them entirely Replied, post #52 · Analytics › Impurities & related substances · 5 Jan 2026 · 25 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Waist circumference technique and its repeatability Replied, post #31 · Outcomes › Progress reports · 26 Dec 2025 · 14 likes post #30 answers the question as asked. The question underneath it is different. Plateaus and resets: if weight loss stalls and then resumes, that is ordinary. It is…
-
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #49 · Sourcing › Vendor reports · 24 Dec 2025 · 10 likes Lot matching: confirm the lot number on the certificate matches the lot number on the vial. A result from a different lot is not evidence about your vial.
-
Personal import allowances, compared Replied, post #10 · Access › International · 22 Dec 2025 · 10 likes Regulatory position dates: a regulatory position is only current as of when it was written. Rechecking is prudent, especially if you saw it months ago.
-
DXA precision and the least significant change for lean mass Replied, post #79 · Outcomes › Body composition · 17 Dec 2025 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
What a regulator's shortage notice actually authorises — what changed since Replied, post #25 · Sourcing › Regulatory · 17 Dec 2025 · 0 likes I read post #23 twice before replying, because I had assumed the opposite. Import restrictions vary by compound and by jurisdiction: what is a controlled substance in…
-
Reconstitution volumes that produce round numbers, tabulated Replied, post #6 · Practice › Reconstitution · 9 Dec 2025 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Availability by country, dated, with primary sources Replied, post #73 · Access › International · 23 Nov 2025 · 0 likes Language barriers: if you need to communicate with a supplier, clinician, or regulator in a language not your first language, misunderstanding is possible. Clarify when…
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one — one… Replied, post #6 · Compounds › Oral incretins · 12 Nov 2025 · 22 likes I read post #4 twice before replying, because I had assumed the opposite. Oral versus injectable exposure: comparing a 14 mg oral dose with a 0.5 mg injectable dose is…
-
Second pass at: Robustness: the parameters worth deliberately varying Replied, post #25 · Analytics › Method validation · 11 Nov 2025 · 4 likes post #24 answers the question as asked. The question underneath it is different. Transfer between laboratories: a method can be transferred from one lab to another, but…
-
Anxiety in the first weeks: drug, situation, or both — what changed since Replied, post #44 · Wellbeing › Mental health · 31 Oct 2025 · 21 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Payment mechanics and the recovery options that do not exist Replied, post #69 · Sourcing › Payments · 22 Oct 2025 · 3 likes Refund policy before ordering: ask what the policy is if you receive damaged material or if the order is incorrect. Get it in writing or screenshot it.
-
About the North America category Replied, post #6 · Regional › North America · 13 Oct 2025 · 10 likes Cross-border purchase: buying in the US and bringing to Canada or vice versa involves both countries' import rules. The medication is legal but crossing borders with it…
-
A 40-week log with the measurement method stated Replied, post #2 · Outcomes › Progress reports · 11 Oct 2025 · 20 likes Longitudinal report with the method stated: same scale, same time of day, same conditions. A scale is a tool; use the same one each time. Consistency matters more than…
-
An inter-laboratory comparison on one lot, tabulated Replied, post #3 · Analytics › Method validation · 3 Oct 2025 · 1 like For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Titles that describe the question, not the situation — what changed since Replied, post #15 · Start Here › How to Ask · 14 Sep 2025 · 2 likes Coming back to post #13, because the follow-up matters more than the original answer. Disagreement-style questions: "I read this and it contradicts what I heard here,…
-
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #14 · Start Here › How to Ask · 12 Sep 2025 · 3 likes Disagreement-style questions: "I read this and it contradicts what I heard here, which is right?" is answerable. "Is this a bad idea?" without giving the context is not.
-
Tracking that stops updating and then resumes Replied, post #25 · Sourcing › Logistics · 9 Sep 2025 · 0 likes post #24 answers the question as asked. The question underneath it is different. Documentation after arrival: photograph the parcel and its contents on arrival. If…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #48 · Data & Tools › Datasets · 8 Sep 2025 · 0 likes This follows post #45 rather than contradicting it. Temporal bias: older data in a dataset might reflect conditions (supplier, formulation, context) that have changed.…
-
An emergency department visit, described afterwards Replied, post #63 · Safety › Adverse events · 6 Sep 2025 · 6 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Journal club: STEP-HFpEF and symptom endpoints Replied, post #14 · Evidence › Journal club · 4 Sep 2025 · 28 likes Worth separating two things that post #10 runs together. Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design answer that…
-
Tirzepatide molecular mass and the charge states you would expect on ESI Started this topic · Compounds › Tirzepatide · 22 Aug 2025 · 2 likes Tirzepatide molecular mass and the charge states you would expect on ESI Writing it up because I had to work it out twice and would rather nobody else did. I have seen…
-
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #8 · Compounds › Semaglutide · 16 Aug 2025 · 0 likes Approved indications differ by jurisdiction and change. As of mid-2026 the weight-management indication is approved in many European jurisdictions but not all, and…
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #108 · Compounds › Semaglutide · 8 Aug 2025 · 19 likes Gastric emptying delay is the mechanism behind most of the gastrointestinal side effects. Slowing the stomach empties it feeds less food into the intestines at a time,…
-
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #25 · Compounds › Oral incretins · 7 Aug 2025 · 18 likes Oral bioavailability is variable between people. Some people absorb well; others absorb poorly. That inter-individual variation is larger than with injectables and is…
-
How to research a compound with no human data without deceiving yourself Replied, post #26 · Compounds › Other compounds · 31 Jul 2025 · 1 like Compounds this community declines to help with, and why: there are specifics in the guidelines and they are not arbitrary. They exist because of failure modes that have…
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #14 · Compounds › Secretagogues & GH axis · 26 Jul 2025 · 1 like Development history is more informative than speculation: ipamorelin was investigated clinically for post-operative ileus and was not taken forward to registration.…
-
Canadian access and provincial variation — one year on Replied, post #3 · Regional › North America · 18 Jul 2025 · 2 likes Coming back to the opening post, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #135 · Compounds › Tirzepatide · 13 Jul 2025 · 0 likes The GIP component: GIP receptor agonism is thought to amplify the GLP-1 effect on satiety and energy expenditure, but how much of tirzepatide's effect is that and how…
-
What this community means by "a source", in practical terms Replied, post #29 · Start Here › Welcome · 9 Jul 2025 · 11 likes post #28 is right about the mechanism and I think understates the practical bit. Trust levels accumulate over time and they give you access to small things like the…
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #62 · Compounds › Repair & healing peptides · 8 Jul 2025 · 1 like Oral versus injected administration claims for BPC-157: the preclinical work studied injection. Oral claims are common in supplier marketing and poorly supported by…
-
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #44 · Sourcing › Regulatory · 7 Jul 2025 · 15 likes Research-use-only status is a legal classification, not a safety classification. It means the compound is sold for laboratory use and not for human consumption. The…
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #77 · Practice › Storage & stability · 2 Jul 2025 · 2 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #16 · Practice › Reconstitution · 25 Jun 2025 · 1 like The decimal-point error: computing 5 mg / 2 mL as 0.25 mg/mL instead of 2.5 mg/mL is the most common arithmetic error in this subcategory. The habit that catches it:…
-
Triple agonism: additive, synergistic, or neither? Replied, post #58 · Compounds › Retatrutide · 18 Jun 2025 · 0 likes Mass and identity: a report on retatrutide should state the mass detected by LC-MS, not assume a theoretical mass. The theoretical mass is not published in…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #98 · Access › Insurance & coverage · 13 Jun 2025 · 10 likes Formulary status: the list of covered medications and the tier (how much you pay) they are on. Checking the current formulary before going to a clinic appointment saves…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #130 · Practice › Reconstitution · 9 Jun 2025 · 18 likes post #129 answers the question as asked. The question underneath it is different. Foaming during reconstitution: bubbles in the solution are usually just air…
-
Half-life, steady state, and accumulation worked through Replied, post #74 · Pharmacology › Pharmacokinetics · 6 Jun 2025 · 28 likes Volume of distribution: the theoretical volume the drug distributes into. For albumin-binding compounds, volume is reduced compared to drugs that do not bind protein.…
-
Second pass at: Retatrutide mass and identity: what a report should show Replied, post #59 · Compounds › Retatrutide · 3 Jun 2025 · 20 likes Picking up post #56: that is the part I would want checked first. Triple agonism: is the effect additive, synergistic, or neither? A phase 2 comparison of tirzepatide…
-
Forced degradation studies: designing one that is informative — does this still hold? Replied, post #8 · Analytics › Method validation · 3 Jun 2025 · 1 like post #7 answers the question as asked. The question underneath it is different. Linearity: the detector response is proportional to compound concentration across the…
-
High-resolution MS on aggregates and what it can see Started this topic · Analytics › Mass spectrometry · 31 May 2025 · 1 like Posting this under the heading it deserves: High-resolution MS on aggregates and what it can see Everything below is what sits behind that. Working through the identity…
-
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #20 · Evidence › Journal club · 30 May 2025 · 13 likes SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome trial in people without diabetes, which decoupled the cardiovascular…
-
Follow-up: Tesamorelin has an approved indication — what that changes about the evidence Replied, post #66 · Compounds › Secretagogues & GH axis · 20 May 2025 · 5 likes Evidence quality in the secretagogue literature is honestly weaker than in the incretin literature. Large randomised controlled trials are rare. Most evidence is…
-
Pregnancy as an absolute contraindication Replied, post #83 · Safety › Contraindications · 20 May 2025 · 12 likes Severe renal impairment (eGFR
-
Follow-up: History of disordered eating and why it changes the conversation Replied, post #10 · Clinical › Special populations · 17 May 2025 · 23 likes On post #6 — agreed on the reasoning, with one qualification. Gastroparesis: pre-existing severe delayed gastric emptying can worsen with compounds that slow it…
-
HbA1c lag and what it can and cannot tell you at eight weeks Replied, post #17 · Clinical › Bloodwork · 14 May 2025 · 14 likes Biological variation: the person-to-person variation in a biomarker for a healthy person is larger than most people realize. Comparing your result to the reference…
-
IGF-1 as a surrogate endpoint and its limitations — the long version Replied, post #3 · Compounds › Secretagogues & GH axis · 13 May 2025 · 10 likes post #2 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Second pass at: Reading a combination trial: attributing effect to components Replied, post #12 · Compounds › Cagrilintide & amylin analogues · 4 May 2025 · 12 likes I read post #10 twice before replying, because I had assumed the opposite. Historical amylin analogues: pramlintide was the only long-acting amylin analogue licensed…
-
An emergency department visit, described afterwards Replied, post #16 · Safety › Adverse events · 30 Apr 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Validating a calculator against hand arithmetic — what changed since Replied, post #37 · Data & Tools › Calculators · 27 Apr 2025 · 1 like Storage lookup: which conditions (temperature, time) are you considering storing in, and how much stability loss is expected? The calculator gives a rough estimate…
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #111 · Documentation › Doc review · 17 Apr 2025 · 1 like Coming back to post #109, because the follow-up matters more than the original answer. New maintainer recruitment: if a page's maintainer is inactive and updates are…
-
Carryover and the ghost peak from last week's standard Replied, post #79 · Analytics › HPLC & UHPLC · 11 Apr 2025 · 13 likes I read post #77 twice before replying, because I had assumed the opposite. This is why a purity figure without the underlying chromatogram is weaker evidence than it…
-
Distinguishing a deletion sequence by mass alone — the long version Replied, post #13 · Analytics › Mass spectrometry · 7 Apr 2025 · 5 likes I read post #11 twice before replying, because I had assumed the opposite. Common adducts: sodium adds ≈22, potassium adds ≈38 compared to hydrogen. A [M+Na]+ peak is…
-
Carryover and the ghost peak from last week's standard Replied, post #10 · Analytics › HPLC & UHPLC · 1 Apr 2025 · 12 likes Coming back to post #8, because the follow-up matters more than the original answer. Reversed-phase separates on hydrophobicity. A peptide is retained on a non-polar…
-
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #12 · Compounds › Oral incretins · 31 Mar 2025 · 12 likes PIONEER programme is phase 3 for oral semaglutide. The trials cover multiple indications and durations. Reading them requires attention to which trial is which because…
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #139 · Analytics › COA interpretation · 29 Mar 2025 · 5 likes Picking up post #136: that is the part I would want checked first. Amino acid analysis gives content: it hydrolyses the peptide and quantifies the residues. It measures…
-
Telehealth prescribing models in the US Replied, post #77 · Regional › North America · 29 Mar 2025 · 23 likes Canada: Health Canada licenses compounds. Prescribing is provincial. Compounds are prescription-only. Coverage varies between public and private insurance.
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #93 · Access › International · 11 Mar 2025 · 0 likes Customs and import outcomes: different routes have different seizure rates. Some countries are stricter on peptide imports than others. History on a route is more…
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #60 · Pharmacology › Receptor biology · 8 Mar 2025 · 15 likes Central versus peripheral action: GLP-1 agonism works through both central nervous system effects (appetite) and peripheral effects (gastric motility, insulin). The…
-
Validating a method you did not develop — does this still hold? Replied, post #81 · Analytics › Method validation · 6 Mar 2025 · 20 likes I read post #79 twice before replying, because I had assumed the opposite. Precision and repeatability: within-run and between-run variability of the method. Acceptance…
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #37 · Documentation › Doc review · 27 Feb 2025 · 14 likes Multilingual versions: if a maintained page should exist in another language, suggesting it here with your willingness to help translate can make it happen.
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #29 · Analytics › COA interpretation · 26 Feb 2025 · 8 likes post #28 is right about the mechanism and I think understates the practical bit. Reading old certificates: if a certificate is dated years ago, the lot it describes…
-
Second pass at: A history of disordered eating: proceeding carefully Replied, post #7 · Wellbeing › Mental health · 16 Feb 2025 · 19 likes post #6 answers the question as asked. The question underneath it is different. Identity and self-image: for some people, weight and body size are central to identity.…
-
Canadian access and provincial variation Replied, post #80 · Regional › North America · 11 Feb 2025 · 14 likes post #79 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #86 · Evidence › Meta-analyses · 10 Feb 2025 · 0 likes I read post #84 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say…
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #84 · Data & Tools › Calculators · 9 Feb 2025 · 12 likes Picking up post #81: that is the part I would want checked first. Storage lookup: which conditions (temperature, time) are you considering storing in, and how much…
-
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #75 · Evidence › Meta-analyses · 8 Feb 2025 · 1 like Study quality and weighting: some meta-analyses weight all studies equally; others weight by study size or study quality. The choice affects the result and should be…
-
Scheduled maintenance and what will be unavailable Replied, post #36 · Meta › Announcements · 7 Feb 2025 · 0 likes Notifications: watching this subcategory means you receive notifications when announcements are posted. Useful if you want to stay current.
-
Second pass at: Transit times by route, from a logged dataset Replied, post #3 · Sourcing › Logistics · 11 Jan 2025 · 8 likes Import restrictions by jurisdiction: what is legal to import for personal use varies enormously by country. Some jurisdictions are quite permissive; others are not.…
-
Dose numbers for oral formulations are not comparable to injectable ones — a second… Replied, post #19 · Compounds › Oral incretins · 4 Jan 2025 · 4 likes Trial adherence in an oral trial with strict administration requirements is genuinely worse than trial-published data often suggests. That is why the exposure…
-
Isotonicity and what happens when you get it wrong Replied, post #14 · Pharmacology › Formulation chemistry · 1 Jan 2025 · 23 likes Lyophilisation and reconstitution: the powder is stable for extended periods if kept cool and dry. Once reconstituted, stability decreases because the dissolved peptide…
-
What we do not know about retatrutide, listed explicitly Replied, post #36 · Compounds › Retatrutide · 28 Dec 2024 · 0 likes Glucagon receptor agonism seems paradoxical in a weight-loss compound because glucagon raises blood glucose. The paradox resolves because glucagon agonism also…
-
Why mass spectrometry cannot tell you about an epimer Replied, post #13 · Analytics › Mass spectrometry · 28 Dec 2024 · 5 likes Common adducts: sodium adds ≈22, potassium adds ≈38 compared to hydrogen. A [M+Na]+ peak is common and its mass is predictable from the base mass.
-
Body image changing more slowly than the body Replied, post #128 · Wellbeing › Mental health · 25 Dec 2024 · 14 likes I read post #126 twice before replying, because I had assumed the opposite. When to involve a professional: if mood changes are persistent, deepen over weeks, or…
-
Second pass at: How to research a compound with no human data without deceiving yourself Replied, post #7 · Compounds › Other compounds · 24 Dec 2024 · 0 likes Why catalogue breadth is not evidence of anything: a supplier listing 500 compounds does not make the 450 untested ones likely to work. It makes them untested compounds…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #49 · Sourcing › Regulatory · 22 Dec 2024 · 0 likes Approval versus licensing: a compound can be approved for a specific indication in one country and not approved at all in another. Tracking jurisdictional approval is…
-
Converting between mg/mL and units per dose, both directions Replied, post #139 · Practice › Reconstitution · 21 Dec 2024 · 0 likes post #138 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Body image changing more slowly than the body Replied, post #34 · Wellbeing › Mental health · 14 Dec 2024 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Revisiting: Moderation log format change Replied, post #66 · Meta › Announcements · 13 Dec 2024 · 0 likes Implementation timeline: announcements include when a change takes effect. Marking the date helps you know whether the change is already in effect.
-
Criticising the method without criticising the authors Replied, post #21 · Evidence › Study critique · 2 Dec 2024 · 0 likes Criticise the method, not the author: a paper with a weak design is not a bad paper by someone with bad intentions. It is a paper that answers a limited question.…
-
Why "any advice?" is the least effective ending for a post Replied, post #74 · Start Here › How to Ask · 26 Nov 2024 · 16 likes Coming back to post #72, because the follow-up matters more than the original answer. What you have already read matters. Saying "I read the maintained page on this and…
-
Type 1 diabetes: off-label use and the evidence gap — what changed since Replied, post #77 · Clinical › Special populations · 26 Nov 2024 · 30 likes This follows post #74 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
Time to steady state after a dose increase Replied, post #142 · Pharmacology › Pharmacokinetics · 6 Nov 2024 · 26 likes Picking up post #139: that is the part I would want checked first. Accumulation at steady state: with a week-long half-life, steady-state concentration is reached…
-
Transit times by route, from a logged dataset — the long version Replied, post #23 · Sourcing › Logistics · 24 Oct 2024 · 1 like Insurance and carrier liability: most parcel carriers limit liability. Understanding the limits before choosing a carrier matters if you are shipping expensive material.
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #75 · Clinical › Bloodwork · 2 Oct 2024 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Hepatic effects of glucagon receptor agonism: the mechanistic worry Replied, post #32 · Compounds › Retatrutide · 12 Sep 2024 · 7 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
How to ask for a dose change without antagonising anyone Replied, post #22 · Clinical › Prescriber conversations · 5 Sep 2024 · 0 likes Asking about monitoring: understand what lab work will be done, how often, and what you will be monitored for. A plan is better than ad-hoc monitoring.
-
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #29 · Sourcing › Independent verification · 1 Sep 2024 · 13 likes Blind sampling: submitting without the laboratory or seller knowing the source removes the two easiest ways for a result to be shaped: selective submission and…
-
Promotion criteria, and the one that stops most nominations Replied, post #49 · Documentation › Doc review · 29 Aug 2024 · 1 like On post #45 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what…
-
[2026 update] People with a low starting BMI: where the evidence stops Replied, post #4 · Clinical › Special populations · 27 Aug 2024 · 0 likes Pregnancy and planning: these compounds are not approved for use in pregnancy. Planning windows (how long to wait before attempting pregnancy) are not formally…
-
Reporting a discrepancy without making an allegation Replied, post #25 · Sourcing › Vendor reports · 13 Aug 2024 · 0 likes Temporal patterns: if results from a supplier were good two years ago but have deteriorated recently, that is information. If they have been consistent over years, that…
-
Circumference measurements as a poor man's composition estimate Replied, post #59 · Outcomes › Body composition · 11 Aug 2024 · 4 likes I read post #57 twice before replying, because I had assumed the opposite. Visceral fat: DXA does not distinguish visceral (organ-associated) fat from subcutaneous fat.…
-
Second pass at: Journal club: LEADER as the historical anchor Replied, post #79 · Evidence › Journal club · 29 Jul 2024 · 1 like On post #75 — agreed on the reasoning, with one qualification. Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design answer that…
-
Assessing a warm arrival: the decision process — one year on Replied, post #106 · Sourcing › Logistics · 1 Jun 2024 · 0 likes Declaring contents accurately: declaring accurately reduces intervention risk. A declaration of "peptide research chemical, 5 grams" is better than "vitamin" or "other"…